News for 'Sun Pharma'

Sensex jumps 938 pts, Nifty settles above 23,400 on bargain buying

Sensex jumps 938 pts, Nifty settles above 23,400 on bargain buying

Rediff.com16 Mar 2026

Indian stock market benchmarks Sensex and Nifty rebounded by over 1% on Monday, driven by value-buying in banking stocks after a three-day slump. Key gainers included UltraTech Cement, HDFC Bank, and Mahindra & Mahindra.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

Hyderabad claims its place as global MNC destination

Hyderabad claims its place as global MNC destination

Rediff.com18 Feb 2026

Hyderabad is rapidly emerging as a strategic hub for multinational companies (MNCs) deepening their focus on artificial intelligence (AI), life sciences, and global capability centres (GCCs), supported by the city's strong pharmaceutical (pharma) base, deeptech talent pool, and a policy environment that encourages high-value investment.

Markets Crash Nearly 2%: BSE Sensex tumbled 1,342 pts; NSE Sinks Below 24K

Markets Crash Nearly 2%: BSE Sensex tumbled 1,342 pts; NSE Sinks Below 24K

Rediff.com11 Mar 2026

Indian stock market indices Sensex and Nifty experienced a significant decline, driven by rising crude oil prices, sustained foreign fund outflows, and selling pressure in major bank stocks.

Stock markets recover on buying in IT, PSU bank stocks

Stock markets recover on buying in IT, PSU bank stocks

Rediff.com20 Mar 2026

Indian equity markets experienced a volatile session, with the Sensex and Nifty recovering some ground after a significant plunge the previous day. Gains were driven by PSU bank, IT, and metal stocks, but concerns over rising fuel prices and geopolitical tensions limited the recovery.

Chhattisgarh Doctor Sentenced in Sterilisation Deaths Case

Chhattisgarh Doctor Sentenced in Sterilisation Deaths Case

Rediff.com18 Mar 2026

A surgeon in Chhattisgarh has been sentenced to two years in jail in connection with the deaths of 12 women following sterilisation surgeries he performed in 2014.

Hiring Outlook Brightens for FY27

Hiring Outlook Brightens for FY27

Rediff.com26 Mar 2026

Hiring demand strongest in ecommerce, tech startups, healthcare, and energy sectors, with Bengaluru, Hyderabad, and Pune leading.

'I Was Laid Off Due To AI'

'I Was Laid Off Due To AI'

Rediff.com26 Feb 2026

rediffGURU Pankaj Vyavahare, career counsellor and life coach, explains how you can survive in the age of AI.

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Rediff.com26 Sep 2025

Most pharma shares dropped, dragging the BSE Healthcare index down by 2.14 per cent after Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1. Wockhardt shares tanked 9.4 per cent.

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

Emma Stone's Oscar-Worthy Turn In Bugonia

Emma Stone's Oscar-Worthy Turn In Bugonia

Rediff.com3 Mar 2026

Bugonia's ending, though not unexpected, is still shocking, reveals Deepa Gahlot.

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

Rediff.com12 Aug 2025

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.

Stock Market Today March 6, 2026: Sensex, Nifty dive over 1% on boiling crude price

Stock Market Today March 6, 2026: Sensex, Nifty dive over 1% on boiling crude price

Rediff.com6 Mar 2026

Indian stock market benchmark indices Sensex and Nifty experienced a significant decline, driven by escalating tensions in the Middle East and rising crude oil prices.

Sensex rises 329 pts on rally in pharma, banking shares

Sensex rises 329 pts on rally in pharma, banking shares

Rediff.com10 Oct 2025

Among the Sensex firms, State Bank of India, Maruti Suzuki India, Axis Bank, NTPC, BEL, Adani Ports, Eternal, Sun Pharmaceuticals, Power Grid, ITC, UltraTech Cement, Trent, HCL Technologies, Mahindra & Mahindra, and HDFC Bank were the major gainers. On the other hand, Tata Steel, Tata Consultancy Services, Tech Mahindra, Titan, Bajaj Finserv, Tata Motors, Bharti Airtel and Bajaj Finance were among the laggards.

Pharma cos may see short-term price blip: Ind-Ra

Pharma cos may see short-term price blip: Ind-Ra

Rediff.com27 Aug 2025

Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

Stock Market Today March 9, 2026: Sensex tanks 1,353 points

Stock Market Today March 9, 2026: Sensex tanks 1,353 points

Rediff.com9 Mar 2026

Indian equity markets experienced a significant downturn, with the Sensex and Nifty plummeting due to rising crude oil prices, geopolitical tensions in West Asia, and continuous foreign fund outflows.

Indian Exports See Marginal Decline in February Amid Geopolitical Tensions

Indian Exports See Marginal Decline in February Amid Geopolitical Tensions

Rediff.com16 Mar 2026

India's merchandise exports experienced a slight decrease in February, while imports surged due to increased gold and silver purchases, leading to a widened trade deficit. The West Asia crisis is expected to further impact trade in the coming months.

Stock Market Today: Sensex, Nifty suffer major meltdown as West Asia crisis intensifies

Stock Market Today: Sensex, Nifty suffer major meltdown as West Asia crisis intensifies

Rediff.com2 Mar 2026

Indian benchmark equity indices Sensex and Nifty experienced a significant crash in early trade, triggered by a sharp increase in crude oil prices and escalating tensions in the Middle East.

Stock Markets Today: Sensex, Nifty50 End Marginally Higher In Volatile Trade

Stock Markets Today: Sensex, Nifty50 End Marginally Higher In Volatile Trade

Rediff.com25 Feb 2026

Indian equities on Dalal Street saw volatility. Track Sensex, Nifty50 movement and key market drivers for Feb 25, 2026.

Stock Market Today Feb 26, 2026: Sensex, Nifty End Mixed In Volatile Trade

Stock Market Today Feb 26, 2026: Sensex, Nifty End Mixed In Volatile Trade

Rediff.com26 Feb 2026

Indian equity markets experienced a volatile trading day, with the Sensex and Nifty closing almost flat. Market sentiment was influenced by global cues, US-Iran talks, and profit-booking activities.

Patients to benefit from GST cut, but pharma firms may face margin pressure

Patients to benefit from GST cut, but pharma firms may face margin pressure

Rediff.com12 Sep 2025

The rationalisation of goods and services tax (GST), announced on Wednesday, directly lowers the cost of everyday medical consumables, and also high-end therapies in oncology and rare diseases, helping reduce out-of-pocket patient expenditure and better adherence to medication.

Can MFN Pricing Reshape India-US Pharma Equation?

Can MFN Pricing Reshape India-US Pharma Equation?

Rediff.com5 Jun 2025

US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent).

Oscar Fever Kickstarts On OTT This Week

Oscar Fever Kickstarts On OTT This Week

Rediff.com27 Feb 2026

The Oscar fever kickstarts with this week's OTT menu. Take your pick from Sukanya Verma's eclectic menu.

Sensex surged 2,073 points at close, Nifty ended at 25,728

Sensex surged 2,073 points at close, Nifty ended at 25,728

Rediff.com3 Feb 2026

Stock market benchmark indices Sensex and Nifty ended 2.5 per cent higher on Tuesday after India and the US agreed to a trade deal under which Washington will bring down the reciprocal tariff on Indian goods to 18 per cent.

How stock markets will fare on this Budget Day

How stock markets will fare on this Budget Day

Rediff.com1 Feb 2026

Bharat Electronics, Power Grid, NTPC and HDFC Bank were among the other major gainers. However, Infosys, Tata Steel, Eternal and Tech Mahindra were among the laggards.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

Will MBA In Dubai Earn Over Rs 18 LPA?

Will MBA In Dubai Earn Over Rs 18 LPA?

Rediff.com4 Feb 2026

rediffGURU Patrick D'souza, CAT expert and founder of Patrick100 explains how to pick a management course and college that will boost your career.

10 Stocks That May Gain From Budget

10 Stocks That May Gain From Budget

Rediff.com4 Feb 2026

The fiscal tilt towards capex benefits companies in investment-related sectors like capital goods, defence equipment, engineering & construction and metal & mining. The planned cut in revenue expenditure will weigh on companies in consumption sectors like FMCG, consumer durables and retail.

Sensex reclaims 84K-mark; Nifty ends up 174 points

Sensex reclaims 84K-mark; Nifty ends up 174 points

Rediff.com9 Feb 2026

Benchmark equity indices Sensex and Nifty extended their gains for the second straight session on Monday, driven by optimism over the India-US trade deal and robust buying in public sector banks, consumer durables, and realty stocks.

STT hike on Futures drags markets down; Sensex crashes 1,547 points

STT hike on Futures drags markets down; Sensex crashes 1,547 points

Rediff.com1 Feb 2026

Benchmark stock indices Sensex and Nifty dived sharply by nearly 2 per cent on Sunday after Finance Minister Nirmala Sitharaman proposed a hike in the Securities Transaction Tax (STT) on derivatives. Reversing the early gains, the 30-share BSE Sensex plunged sharply by 2,370.36 points or 2.88 per cent to slide below the 80,000-mark at 79,899.42 in afternoon trade as the finance minister announced a hike in STT on futures contracts to 0.05 per cent from the current 0.02 per cent.

Why The Markets Fell After 12.10 PM

Why The Markets Fell After 12.10 PM

Rediff.com1 Feb 2026

Ambareesh Baliga's quick take on the markets after the increase in STT on futures and options trading...

Budget 2026 boosts healthcare spend, drugs relief

Budget 2026 boosts healthcare spend, drugs relief

Rediff.com1 Feb 2026

The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, including those aimed at making India a global hub for allied healthcare professionals and biopharma manufacturing.

Indian pharma firms not copying products of Swiss cos: Goyal

Indian pharma firms not copying products of Swiss cos: Goyal

Rediff.com10 Jun 2025

Dismissing allegations that Indian phacosrmaceutical companies copy products of Swiss firms, Commerce and Industry Minister Piyush Goyal on Tuesday said it is a long-standing myth and India respects intellectual property rights and never steals technology from others. He said that Swiss pharmaceutical companies have not shown even a single instance that Indian companies have illegally copied any of their trademarks or patents or copyrighted technology.

Budget 2026 is cautious and also focussed on the long-term journey

Budget 2026 is cautious and also focussed on the long-term journey

Rediff.com10 Feb 2026

This year's Economic Survey and the Union Budget were more closely followed for more reasons than one.

What India gives, and what it gets: Highlights of India-US interim trade deal

What India gives, and what it gets: Highlights of India-US interim trade deal

Rediff.com7 Feb 2026

Both countries commit to provide each other preferential market access in sectors of respective interest on a sustained basis

Market Guru: 'This Is About Capital Preservation'

Market Guru: 'This Is About Capital Preservation'

Rediff.com18 Feb 2026

'The problem is not just slower growth, but also the quality of growth.'

India, US to sign interim trade deal in March: Goyal

India, US to sign interim trade deal in March: Goyal

Rediff.com20 Feb 2026

Commerce and Industry Minister Piyush Goyal announced that an interim trade agreement between India and the US is likely to be signed in March and operationalised in April, with chief negotiators meeting in Washington to finalize the details.

Sensex drops 245 points on persistent foreign fund outflows

Sensex drops 245 points on persistent foreign fund outflows

Rediff.com14 Jan 2026

From the 30-Sensex firms, Tata Consultancy Services, Asian Paints, Maruti, Sun Pharma, Hindustan Unilever, ICICI Bank, Kotak Mahindra Bank, Tech Mahindra, HDFC Bank and Larsen & Toubro were among the biggest laggards. On the other hand, Tata Steel, NTPC, Axis Bank and UltraTech Cement were among the gainers.